Skip to content

PCT of Pharmacopuncture Therapy for Chronic Low Back Pain : A Pilot Study

Pragmatic Randomized Controlled Trial of Pharmacopuncture Therapy for Chronic Low Back Pain : A Pilot Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04576520
Enrollment
32
Registered
2020-10-06
Start date
2020-10-13
Completion date
2021-03-26
Last updated
2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Low-back Pain

Brief summary

This is pilot study for a 2-arm parallel pragmatic randomized controlled trial that will compare pharmacopuncture therapy and physical therapy for chronic low back pain.

Detailed description

This is a pragmatic RCT, so the physicians will choose the type and volume of pharmacopuncture and the type and time of physical therapy according to participants' conditions, respectively.

Interventions

This is a pragmatic RCT, so the physicians will choose the type and volume of pharmacopuncture according to participants' conditions.

PROCEDUREphysical therapy

This is a pragmatic RCT, so the physicians will choose the type and time of physical therapy according to participants' conditions.

Sponsors

Jaseng Medical Foundation
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
19 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

1. low back pain for more than 6 months 2. Visual Analogue Scale (VAS) of low back pain is more than 5 3. 19-70 years old 4. participants who agreed and wrote informed consents

Exclusion criteria

1. Migration of cancer reaching to spine, fracture of spine 2. Progressive neurologic deficits or severe neurologic deficits 3. Cancer, fibromyalgia, RA, or goat 4. Stroke, MI, kidney disease, dimentia, diabetic neuropathy, or epilepsy 5. Participants taking steroid, immunosuppressant, or psychotropic medication 6. Hemorrhagic disease, severe diabetes or taking anticoagulant drug 7. Participants who took NSAIDs or pharmacopuncture within 1 week 8. Pregnant or lactating women 9. Participants who had undergone cervical surgery within 3 months 10. Participants who had participated in other clinical trial within 1 month, or have plan for participation in other trial during follow up period of this trial 11. Participants who can not write informed consent 12. Participants who is difficult to participate in the trial according to investigator's decision

Design outcomes

Primary

MeasureTime frameDescription
Visual analogue scale (VAS) of low back painChange from baseline VAS at week 6Visual analogue scale of low back pain, minimum 0 to maximum 100, which is a higher score means a worse outcome.

Secondary

MeasureTime frameDescription
Numeric rating scale (NRS) of low back pain and leg radiating painWeek 1, 2, 3, 4, 5, 6, 10, 16NRS is a pain scale in which the patient indicates their subjective pain as a whole number from 0 to 10, where 0 indicates 'no pain or discomfort' and 10 indicates 'the most severe pain and discomfort imaginable'.
Oswestry Disability Index (ODI)Week 1, 6, 10, 16ODI is a functional disability questionnaire. The possible range of each item score is 0 to 5. Total score range is 0 (better outcome) to 100 (worse outcome).
Korean version of the Roland-Morris Disability Questionnaire (RMDQ)Week 1, 6, 10, 16The Roland Morris Disability Questionnaire consists of 24 statements relating to the person's perceptions of their back pain and associated disability. This includes items on physical ability/activity (15), sleep/rest (3), psychosocial (2), household management (2), eating (1) and pain frequency (1). There is no weighting applied to the statements, therefore the score can range from 0 (no disability) to 24 (maximal disability).
Visual analogue scale (VAS) of leg radiating painWeek 1, 2, 3, 4, 5, 6, 10, 16Visual analogue scale of radiating leg pain, minimum 0 to maximum 100, which is a higher score means a worse outcome.
Short Form-12 Health Survey version 2 (SF-12 v2)Week 1, 6, 10, 16The SF-12 consists of 12 questions across 8 domains, and higher scores indicate better health-related quality of life.
EuroQol-5 Dimension (EQ-5D-5L)Week 1, 6, 10, 16The EQ-5D-5L consists of 5 questions (mobility, self-care, usual activities, pain, anxiety/depression) that ask about the current state of health, and answers each question with 5 likert. (1=I have no problems about, 2=I have slight problems about, 3=I have moderate problems about, 4=I have severe problems about, 5=I am unable to about)
Patient Global Impression of Change (PGIC)Week 6, 10, 16Participants rate the improvement after treatment on a 7-point Likert scale (1, very much improved; 2, much improved; 3, minimally improved; 4, no change; 5, minimally worse; 6, much worse; or 7, very much worse.)

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026